<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37045868</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>12</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Mutant and curli-producing E. coli enhance the disease phenotype in a hSOD1-G93A mouse model of ALS.</ArticleTitle><Pagination><StartPage>5945</StartPage><MedlinePgn>5945</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5945</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-32594-5</ELocationID><Abstract><AbstractText>The gut microbiome is a potential non-genetic contributing factor for Amyotrophic Lateral Sclerosis. Differences in gut microbial communities have been detected between ALS subjects and healthy controls, including an increase in Escherichia coli in ALS subjects. E. coli and other gram-negative bacteria produce curli proteins, which are functional bacterial amyloids. We examined whether long-term curli overexposure in the gut can exacerbate the development and progression of ALS. We utilized the slow-developing hSOD1-G93A mouse model of ALS with their C57BL/6J WT littermate controls, including males and females, with a total of 91 animals. These mice were on a normal chow diet and fed curli-producing or curli-nonproducing (mutant) E. coli in applesauce (vehicle) 3 times/week, from 1 through 7 months of age. Male hSOD1 mice demonstrated gradual slowing in running speed month 4 onwards, while females exhibited no signs of locomotive impairment even at 7 months of age. Around the same time, male hSOD1 mice showed a gradual increase in frequency of peripheral CD19<sup>+</sup> B cells. Among the male hSOD1 group, chronic gut exposure to curli-producing E. coli led to significant shifts in &#x3b1;- and &#x3b2;-diversities. Curli-exposed males showed suppression of immune responses in circulation, but an increase in markers of inflammation, autophagy and protein turnover in skeletal muscle. Some of these markers were also changed in mutant E. coli-exposed mice, including astrogliosis in the brainstem and demyelination in the lumbar spinal cord. Overall, chronic overexposure to a commensal bacteria like E. coli led to distant organ pathology in our model, without the presence of a leaky gut at 6 months. Mechanisms underlying gut-distant organ communication are of tremendous interest to all disciplines.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kurlawala</LastName><ForeName>Zimple</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Louisville, Louisville, KY, 40202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMillan</LastName><ForeName>Joseph D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, University of South Florida, Tampa, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singhal</LastName><ForeName>Richa A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>KY IDeA Networks of Biomedical Research Excellence Bioinformatics Core, University of Louisville, Louisville, KY, 40202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morehouse</LastName><ForeName>Johnny</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kentucky Spinal Cord Injury Research Center, University of Louisville, Louisville, KY, 40202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burke</LastName><ForeName>Darlene A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Kentucky Spinal Cord Injury Research Center, University of Louisville, Louisville, KY, 40202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sears</LastName><ForeName>Sophia M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, 40202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duregon</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>National Institute on Aging, Translational Gerontology, NIH, Bethesda, USA, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beverly</LastName><ForeName>Levi J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Louisville, Louisville, KY, 40202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siskind</LastName><ForeName>Leah J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, 40202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedland</LastName><ForeName>Robert P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Louisville, Louisville, KY, 40202, USA. robert.friedland@louisville.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Robert P. Friedland is a stockholder in Axial Therapeutics. ZK, JDM, RAS, JM, SMS, ED, DAB, LJB, and LJS have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>23</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37045868</ArticleId><ArticleId IdType="pmc">PMC10097672</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-32594-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-32594-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Trojsi F, Monsurro MR, Tedeschi G. Exposure to environmental toxicants and pathogenesis of amyotrophic lateral sclerosis: State of the art and research perspectives. Int. J. Mol. Sci. 2013;14:15286&#x2013;15311. doi: 10.3390/ijms140815286.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms140815286</ArticleId><ArticleId IdType="pmc">PMC3759860</ArticleId><ArticleId IdType="pubmed">23887652</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, Kook M, Foss CA, Shen C, Lee H, Kulkarni S, Pasricha PJ, Lee G, Pomper MG, Dawson VL, Dawson TM, Ko HS. Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson&#x2019;s disease. Neuron. 2019;103(627&#x2013;641):e627. doi: 10.1016/j.neuron.2019.05.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.05.035</ArticleId><ArticleId IdType="pmc">PMC6706297</ArticleId><ArticleId IdType="pubmed">31255487</ArticleId></ArticleIdList></Reference><Reference><Citation>Miraglia F, Colla E. Microbiome, Parkinson&#x2019;s disease and molecular mimicry. Cells. 2019;8:222. doi: 10.3390/cells8030222.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8030222</ArticleId><ArticleId IdType="pmc">PMC6468760</ArticleId><ArticleId IdType="pubmed">30866550</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos SF, de Oliveira HL, Yamada ES, Neves BC, Pereira A., Jr The gut and Parkinson&#x2019;s disease-a bidirectional pathway. Front. Neurol. 2019;10:574. doi: 10.3389/fneur.2019.00574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00574</ArticleId><ArticleId IdType="pmc">PMC6558190</ArticleId><ArticleId IdType="pubmed">31214110</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghammer P, Van Den Berge N. Brain-first versus gut-first Parkinson&#x2019;s disease: A hypothesis. J. Parkinsons Dis. 2019;9:S281&#x2013;S295. doi: 10.3233/JPD-191721.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-191721</ArticleId><ArticleId IdType="pmc">PMC6839496</ArticleId><ArticleId IdType="pubmed">31498132</ArticleId></ArticleIdList></Reference><Reference><Citation>Lionnet A, Leclair-Visonneau L, Neunlist M, Murayama S, Takao M, Adler CH, Derkinderen P, Beach TG. Does Parkinson&#x2019;s disease start in the gut? Acta Neuropathol. 2018;135:1&#x2013;12. doi: 10.1007/s00401-017-1777-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1777-8</ArticleId><ArticleId IdType="pubmed">29039141</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, Chesselet MF, Keshavarzian A, Shannon KM, Krajmalnik-Brown R, Wittung-Stafshede P, Knight R, Mazmanian SK. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson&#x2019;s disease. Cell. 2016;167:1469&#x2013;1480.e1412. doi: 10.1016/j.cell.2016.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.11.018</ArticleId><ArticleId IdType="pmc">PMC5718049</ArticleId><ArticleId IdType="pubmed">27912057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedarf JR, Hildebrand F, Coelho LP, Sunagawa S, Bahram M, Goeser F, Bork P, Wullner U. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson&#x2019;s disease patients. Genome Med. 2017;9:39. doi: 10.1186/s13073-017-0428-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-017-0428-y</ArticleId><ArticleId IdType="pmc">PMC5408370</ArticleId><ArticleId IdType="pubmed">28449715</ArticleId></ArticleIdList></Reference><Reference><Citation>Minato T, Maeda T, Fujisawa Y, Tsuji H, Nomoto K, Ohno K, Hirayama M. Progression of Parkinson's disease is associated with gut dysbiosis: 2-year follow-up study. PLoS ONE. 2017;12:e0187307. doi: 10.1371/journal.pone.0187307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0187307</ArticleId><ArticleId IdType="pmc">PMC5665539</ArticleId><ArticleId IdType="pubmed">29091972</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedland RP. Mechanisms of molecular mimicry involving the microbiota in neurodegeneration. J. Alzheimers Dis. 2015;45:349&#x2013;362. doi: 10.3233/JAD-142841.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-142841</ArticleId><ArticleId IdType="pubmed">25589730</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalski K, Mulak A. Brain-gut-microbiota axis in Alzheimer&#x2019;s disease. J. Neurogastroenterol. Motil. 2019;25:48&#x2013;60. doi: 10.5056/jnm18087.</Citation><ArticleIdList><ArticleId IdType="doi">10.5056/jnm18087</ArticleId><ArticleId IdType="pmc">PMC6326209</ArticleId><ArticleId IdType="pubmed">30646475</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, Ferrari C, Guerra UP, Paghera B, Muscio C, Bianchetti A, Volta GD, Turla M, Cotelli MS, Gennuso M, Prelle A, Zanetti O, Lussignoli G, Mirabile D, Bellandi D, Gentile S, Belotti G, Villani D, Harach T, Bolmont T, Padovani A, Boccardi M, Frisoni GB. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol. Aging. 2017;49:60&#x2013;68. doi: 10.1016/j.neurobiolaging.2016.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.08.019</ArticleId><ArticleId IdType="pubmed">27776263</ArticleId></ArticleIdList></Reference><Reference><Citation>Harach T, Marungruang N, Duthilleul N, Cheatham V, Mc Coy KD, Frisoni G, Neher JJ, Fak F, Jucker M, Lasser T, Bolmont T. Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci. Rep. 2017;7:41802. doi: 10.1038/srep41802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41802</ArticleId><ArticleId IdType="pmc">PMC5297247</ArticleId><ArticleId IdType="pubmed">28176819</ArticleId></ArticleIdList></Reference><Reference><Citation>Minter MR, Hinterleitner R, Meisel M, Zhang C, Leone V, Zhang X, Oyler-Castrillo P, Zhang X, Musch MW, Shen X, Jabri B, Chang EB, Tanzi RE, Sisodia SS. Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE/PS1DeltaE9 murine model of Alzheimer&#x2019;s disease. Sci. Rep. 2017;7:10411. doi: 10.1038/s41598-017-11047-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-11047-w</ArticleId><ArticleId IdType="pmc">PMC5585265</ArticleId><ArticleId IdType="pubmed">28874832</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U, Dori-Bachash M, Kleimeyer C, Moresi C, Harnik Y, Zur M, Zabari M, Brik RB, Kviatcovsky D, Zmora N, Cohen Y, Bar N, Levi I, Amar N, Mehlman T, Brandis A, Biton I, Kuperman Y, Tsoory M, Alfahel L, Harmelin A, Schwartz M, Israelson A, Arike L, Johansson MEV, Hansson GC, Gotkine M, Segal E, Elinav E. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572:474&#x2013;480. doi: 10.1038/s41586-019-1443-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1443-5</ArticleId><ArticleId IdType="pubmed">31330533</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini, L., Mogna, L., De Marchi, F., Amoruso, A., Pane, M., Aloisio, I., Cionci, N. B., Gaggia, F., Lucenti, A., Bersano, E., Cantello, R., Di Gioia, D., &amp; Mogna, G. (2018) Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies, J Clin Gastroenterol 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition &amp; Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017, S68&#x2013;S70.</Citation><ArticleIdList><ArticleId IdType="pubmed">29782468</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gioia D, Bozzi Cionci N, Baffoni L, Amoruso A, Pane M, Mogna L, Gaggia F, Lucenti MA, Bersano E, Cantello R, De Marchi F, Mazzini L. A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis. BMC Med. 2020;18:153. doi: 10.1186/s12916-020-01607-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01607-9</ArticleId><ArticleId IdType="pmc">PMC7298784</ArticleId><ArticleId IdType="pubmed">32546239</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Luo ZY, Hu YY, Bi YW, Yang JM, Zou WJ, Song YL, Li S, Shen T, Li SJ, Huang L, Zhou AJ, Gao TM, Li JM. The gut microbiota regulates autism-like behavior by mediating vitamin B6 homeostasis in EphB6-deficient mice. Microbiome. 2020;8:120. doi: 10.1186/s40168-020-00884-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-020-00884-z</ArticleId><ArticleId IdType="pmc">PMC7441571</ArticleId><ArticleId IdType="pubmed">32819434</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharon G, Cruz NJ, Kang DW, Gandal MJ, Wang B, Kim YM, Zink EM, Casey CP, Taylor BC, Lane CJ, Bramer LM, Isern NG, Hoyt DW, Noecker C, Sweredoski MJ, Moradian A, Borenstein E, Jansson JK, Knight R, Metz TO, Lois C, Geschwind DH, Krajmalnik-Brown R, Mazmanian SK. Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice. Cell. 2019;177(1600&#x2013;1618):e1617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6993574</ArticleId><ArticleId IdType="pubmed">31150625</ArticleId></ArticleIdList></Reference><Reference><Citation>DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current understanding of dysbiosis in disease in human and animal models. Inflamm. Bowel Dis. 2016;22:1137&#x2013;1150. doi: 10.1097/MIB.0000000000000750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MIB.0000000000000750</ArticleId><ArticleId IdType="pmc">PMC4838534</ArticleId><ArticleId IdType="pubmed">27070911</ArticleId></ArticleIdList></Reference><Reference><Citation>Saffouri GB, Shields-Cutler RR, Chen J, Yang Y, Lekatz HR, Hale VL, Cho JM, Battaglioli EJ, Bhattarai Y, Thompson KJ, Kalari KK, Behera G, Berry JC, Peters SA, Patel R, Schuetz AN, Faith JJ, Camilleri M, Sonnenburg JL, Farrugia G, Swann JR, Grover M, Knights D, Kashyap PC. Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders. Nat. Commun. 2019;10:2012. doi: 10.1038/s41467-019-09964-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09964-7</ArticleId><ArticleId IdType="pmc">PMC6494866</ArticleId><ArticleId IdType="pubmed">31043597</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu LX, Schwabe RF. The gut microbiome and liver cancer: Mechanisms and clinical translation. Nat. Rev. Gastroenterol. Hepatol. 2017;14:527&#x2013;539. doi: 10.1038/nrgastro.2017.72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2017.72</ArticleId><ArticleId IdType="pmc">PMC6467288</ArticleId><ArticleId IdType="pubmed">28676707</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Zhou J, Xin Y, Geng C, Tian Z, Yu X, Dong Q. Bacterial overgrowth and diversification of microbiota in gastric cancer. Eur. J. Gastroenterol. Hepatol. 2016;28:261&#x2013;266. doi: 10.1097/MEG.0000000000000542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEG.0000000000000542</ArticleId><ArticleId IdType="pmc">PMC4739309</ArticleId><ArticleId IdType="pubmed">26657453</ArticleId></ArticleIdList></Reference><Reference><Citation>Vipperla K, O'Keefe SJ. The microbiota and its metabolites in colonic mucosal health and cancer risk. Nutr. Clin. Pract. 2012;27:624&#x2013;635. doi: 10.1177/0884533612452012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0884533612452012</ArticleId><ArticleId IdType="pubmed">22868282</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YG, Wu S, Yi J, Xia Y, Jin D, Zhou J, Sun J. Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clin. Ther. 2017;39:322&#x2013;336. doi: 10.1016/j.clinthera.2016.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2016.12.014</ArticleId><ArticleId IdType="pmc">PMC5344195</ArticleId><ArticleId IdType="pubmed">28129947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Yi J, Zhang YG, Zhou J, Sun J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol. Rep. 2015;3:e12356. doi: 10.14814/phy2.12356.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.12356</ArticleId><ArticleId IdType="pmc">PMC4425962</ArticleId><ArticleId IdType="pubmed">25847918</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Lau CY, Ma F, Zheng C. Genome-wide screen identifies curli amyloid fibril as a bacterial component promoting host neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 2021;118:e2106504118. doi: 10.1073/pnas.2106504118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2106504118</ArticleId><ArticleId IdType="pmc">PMC8403922</ArticleId><ArticleId IdType="pubmed">34413194</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampson TR, Challis C, Jain N, Moiseyenko A, Ladinsky MS, Shastri GG, Thron T, Needham BD, Horvath I, Debelius JW, Janssen S, Knight R, Wittung-Stafshede P, Gradinaru V, Chapman M, Mazmanian SK. A gut bacterial amyloid promotes alpha-synuclein aggregation and motor impairment in mice. Elife. 2020;9:e53111. doi: 10.7554/eLife.53111.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.53111</ArticleId><ArticleId IdType="pmc">PMC7012599</ArticleId><ArticleId IdType="pubmed">32043464</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SG, Stribinskis V, Rane MJ, Demuth DR, Gozal E, Roberts AM, Jagadapillai R, Liu R, Choe K, Shivakumar B, Son F, Jin S, Kerber R, Adame A, Masliah E, Friedland RP. Exposure to the functional bacterial amyloid protein curli enhances alpha-synuclein aggregation in aged fischer 344 rats and caenorhabditis elegans. Sci. Rep. 2016;6:34477. doi: 10.1038/srep34477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep34477</ArticleId><ArticleId IdType="pmc">PMC5052651</ArticleId><ArticleId IdType="pubmed">27708338</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetz G, Brown SM, Hao Y, et al. Type 1 Diabetes: an Association Between Autoimmunity, the Dynamics of Gut Amyloid-producing E. coli and Their Phages. Sci. Rep. 2019;9:9685. doi: 10.1038/s41598-019-46087-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-46087-x</ArticleId><ArticleId IdType="pmc">PMC6609616</ArticleId><ArticleId IdType="pubmed">31273267</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: The Keio collection. Mol. Syst. Biol. 2006;2:0008. doi: 10.1038/msb4100050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/msb4100050</ArticleId><ArticleId IdType="pmc">PMC1681482</ArticleId><ArticleId IdType="pubmed">16738554</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend. Med. 2010;7:557&#x2013;570. doi: 10.1016/j.genm.2010.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genm.2010.11.010</ArticleId><ArticleId IdType="pubmed">21195356</ArticleId></ArticleIdList></Reference><Reference><Citation>Beare JE, Morehouse JR, DeVries WH, Enzmann GU, Burke DA, Magnuson DS, Whittemore SR. Gait analysis in normal and spinal contused mice using the TreadScan system. J. Neurotrauma. 2009;26:2045&#x2013;2056. doi: 10.1089/neu.2009.0914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2009.0914</ArticleId><ArticleId IdType="pmc">PMC2813489</ArticleId><ArticleId IdType="pubmed">19886808</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, Rothstein JD. Glial cells in amyotrophic lateral sclerosis. Exp. Neurol. 2014;262:111&#x2013;120. doi: 10.1016/j.expneurol.2014.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.05.015</ArticleId><ArticleId IdType="pmc">PMC4241182</ArticleId><ArticleId IdType="pubmed">24859452</ArticleId></ArticleIdList></Reference><Reference><Citation>Jinquan T, Quan S, Feili G, Larsen CG, Thestrup-Pedersen K. Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4. J. Immunol. 1999;162:4285&#x2013;4292. doi: 10.4049/jimmunol.162.7.4285.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.162.7.4285</ArticleId><ArticleId IdType="pubmed">10201960</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerber BO, Zanni MP, Uguccioni M, Loetscher M, Mackay CR, Pichler WJ, Yawalkar N, Baggiolini M, Moser B. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr. Biol. 1997;7:836&#x2013;843. doi: 10.1016/S0960-9822(06)00371-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(06)00371-X</ArticleId><ArticleId IdType="pubmed">9480044</ArticleId></ArticleIdList></Reference><Reference><Citation>Fife BT, Kennedy KJ, Paniagua MC, Lukacs NW, Kunkel SL, Luster AD, Karpus WJ. CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 2001;166:7617&#x2013;7624. doi: 10.4049/jimmunol.166.12.7617.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.166.12.7617</ArticleId><ArticleId IdType="pubmed">11390519</ArticleId></ArticleIdList></Reference><Reference><Citation>Pertl U, Luster AD, Varki NM, Homann D, Gaedicke G, Reisfeld RA, Lode HN. IFN-&#x3b3;-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy. J. Immunol. 2001;166:6944&#x2013;6951. doi: 10.4049/jimmunol.166.11.6944.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.166.11.6944</ArticleId><ArticleId IdType="pubmed">11359856</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabat R, Ouyang W, Wolk K. Therapeutic opportunities of the IL-22-IL-22R1 system. Nat. Rev. Drug Discov. 2014;13:21&#x2013;38. doi: 10.1038/nrd4176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd4176</ArticleId><ArticleId IdType="pubmed">24378801</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowin J, Xia Y, Jung B, Sun J. Gut inflammation and dysbiosis in human motor neuron disease. Physiol. Rep. 2017;5:e13443. doi: 10.14814/phy2.13443.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.13443</ArticleId><ArticleId IdType="pmc">PMC5617930</ArticleId><ArticleId IdType="pubmed">28947596</ArticleId></ArticleIdList></Reference><Reference><Citation>Valles-Colomer M, Falony G, Darzi Y, Tigchelaar EF, Wang J, Tito RY, Schiweck C, Kurilshikov A, Joossens M, Wijmenga C, Claes S, Van Oudenhove L, Zhernakova A, Vieira-Silva S, Raes J. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat. Microbiol. 2019;4:623&#x2013;632. doi: 10.1038/s41564-018-0337-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0337-x</ArticleId><ArticleId IdType="pubmed">30718848</ArticleId></ArticleIdList></Reference><Reference><Citation>Abenavoli L, Scarpellini E, Colica C, Boccuto L, Salehi B, Sharifi-Rad J, Aiello V, Romano B, De Lorenzo A, Izzo AA, Capasso R. Gut microbiota and obesity: a role for probiotics. Nutrients. 2019;11:2690. doi: 10.3390/nu11112690.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11112690</ArticleId><ArticleId IdType="pmc">PMC6893459</ArticleId><ArticleId IdType="pubmed">31703257</ArticleId></ArticleIdList></Reference><Reference><Citation>Glassner KL, Abraham BP, Quigley EMM. The microbiome and inflammatory bowel disease. J. Allergy Clin. Immunol. 2020;145:16&#x2013;27. doi: 10.1016/j.jaci.2019.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2019.11.003</ArticleId><ArticleId IdType="pubmed">31910984</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Zhou B, Lin MY, Wang S, Foust KD, Sheng ZH. Endolysosomal Deficits augment mitochondria pathology in spinal motor neurons of asymptomatic fALS mice. Neuron. 2015;87:355&#x2013;370. doi: 10.1016/j.neuron.2015.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.06.026</ArticleId><ArticleId IdType="pmc">PMC4511489</ArticleId><ArticleId IdType="pubmed">26182418</ArticleId></ArticleIdList></Reference><Reference><Citation>Settembre C, Ballabio A. TFEB regulates autophagy: An integrated coordination of cellular degradation and recycling processes. Autophagy. 2011;7:1379&#x2013;1381. doi: 10.4161/auto.7.11.17166.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.7.11.17166</ArticleId><ArticleId IdType="pubmed">21785263</ArticleId></ArticleIdList></Reference><Reference><Citation>Murton AJ, Constantin D, Greenhaff PL. The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. Biochim. Biophys. Acta. 2008;1782:730&#x2013;743. doi: 10.1016/j.bbadis.2008.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2008.10.011</ArticleId><ArticleId IdType="pubmed">18992328</ArticleId></ArticleIdList></Reference><Reference><Citation>von Grabowiecki Y, Abreu P, Blanchard O, Palamiuc L, Benosman S, Meriaux S, Devignot V, Gross I, Mellitzer G, de Aguilar JLG. Transcriptional activator TAp63 is upregulated in muscular atrophy during ALS and induces the pro-atrophic ubiquitin ligase Trim63. Elife. 2016;5:e10528. doi: 10.7554/eLife.10528.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.10528</ArticleId><ArticleId IdType="pmc">PMC4786414</ArticleId><ArticleId IdType="pubmed">26919175</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe9;ger B, Vergani L, Sorar&#xf9; G, Hespel P, Derave W, Gobelet C, D'Ascenzio C, Angelini C, Russell AP. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J. 2006;20:583&#x2013;585. doi: 10.1096/fj.05-5249fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.05-5249fje</ArticleId><ArticleId IdType="pubmed">16507768</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartori R, Schirwis E, Blaauw B, Bortolanza S, Zhao J, Enzo E, Stantzou A, Mouisel E, Toniolo L, Ferry A. BMP signaling controls muscle mass. Nat. Genet. 2013;45:1309&#x2013;1318. doi: 10.1038/ng.2772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2772</ArticleId><ArticleId IdType="pubmed">24076600</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodine SC, Baehr LM. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1. Am. J. Physiol.-Endocrinol. Metab. 2014;307:E469&#x2013;E484. doi: 10.1152/ajpendo.00204.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00204.2014</ArticleId><ArticleId IdType="pmc">PMC4166716</ArticleId><ArticleId IdType="pubmed">25096180</ArticleId></ArticleIdList></Reference><Reference><Citation>Pikatza-Menoio O, Elicegui A, Bengoetxea X, Naldaiz-Gastesi N, Lopez de Munain A, Gerenu G, Gil-Bea FJ, Alonso-Martin S. The skeletal muscle emerges as a new disease target in amyotrophic lateral sclerosis. J. Pers. Med. 2021;11:671. doi: 10.3390/jpm11070671.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11070671</ArticleId><ArticleId IdType="pmc">PMC8307751</ArticleId><ArticleId IdType="pubmed">34357138</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G, Aucello M, Rizzuto E, Beccafico S, Mammucari C, Bonconpagni S, Belia S, Wannenes F, Nicoletti C, Del Prete Z. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab. 2008;8:425&#x2013;436. doi: 10.1016/j.cmet.2008.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2008.09.002</ArticleId><ArticleId IdType="pubmed">19046573</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Zhao W, Wang J, Zhang X, Wen S, Neal D, Thonhoff JR, Alsuliman AS, Shpall EJ, Rezvani K, Appel SH. ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity. JCI Insight. 2017;2:e89530. doi: 10.1172/jci.insight.89530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.89530</ArticleId><ArticleId IdType="pmc">PMC5333967</ArticleId><ArticleId IdType="pubmed">28289705</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani S, Garbelli S, Pasini A, Alimonti D, Perotti C, Melazzini M, Bendotti C, Mora G. Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process. J. Neuroimmunol. 2009;210:73&#x2013;79. doi: 10.1016/j.jneuroim.2009.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2009.02.012</ArticleId><ArticleId IdType="pubmed">19307024</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS, Beers DR, Wen S, Rivera AL, Toennis KM, Appel JE, Zhao W, Moore DH, Powell SZ, Appel SH. Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol. Med. 2013;5:64&#x2013;79. doi: 10.1002/emmm.201201544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201201544</ArticleId><ArticleId IdType="pmc">PMC3569654</ArticleId><ArticleId IdType="pubmed">23143995</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen A, Wick MJ, Morgelin M, Bjorck L. Curli, fibrous surface proteins of Escherichia coli, interact with major histocompatibility complex class I molecules. Infect. Immun. 1998;66:944&#x2013;949. doi: 10.1128/IAI.66.3.944-949.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.66.3.944-949.1998</ArticleId><ArticleId IdType="pmc">PMC108000</ArticleId><ArticleId IdType="pubmed">9488380</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Lee JD, Woodruff TM, Henderson RD. The peripheral immune system and amyotrophic lateral sclerosis. Front. Neurol. 2020;11:279. doi: 10.3389/fneur.2020.00279.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00279</ArticleId><ArticleId IdType="pmc">PMC7186478</ArticleId><ArticleId IdType="pubmed">32373052</ArticleId></ArticleIdList></Reference><Reference><Citation>Thonhoff JR, Beers DR, Zhao W, Pleitez M, Simpson EP, Berry JD, Cudkowicz ME, Appel SH. Expanded autologous regulatory T-lymphocyte infusions in ALS: A phase I, first-in-human study. Neurol. (R) Neuroimmunol. Neuroinflammation. 2018;5:e465. doi: 10.1212/NXI.0000000000000465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000465</ArticleId><ArticleId IdType="pmc">PMC5961523</ArticleId><ArticleId IdType="pubmed">29845093</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A, Wells MF, Limone F, Couto A, Smith KS, Keaney J, Gillet G, van Gastel N, Wang JY, Pietilainen O, Qian M, Eggan P, Cantrell C, Mok J, Kadiu I, Scadden DT, Eggan K. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature. 2020;582:89&#x2013;94. doi: 10.1038/s41586-020-2288-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2288-7</ArticleId><ArticleId IdType="pmc">PMC7416879</ArticleId><ArticleId IdType="pubmed">32483373</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C, Guo K, Murdock BJ, Paez-Colasante X, Bassis CM, Mikhail KA, Raue KD, Evans MC, Taubman GF, McDermott AJ, O'Brien PD, Savelieff MG, Hur J, Feldman EL. Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice. Dis. Mod. Mech. 2019;13:dmmo41947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6906635</ArticleId><ArticleId IdType="pubmed">31597644</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, Patterson PH, Mazmanian SK. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155:1451&#x2013;1463. doi: 10.1016/j.cell.2013.11.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.11.024</ArticleId><ArticleId IdType="pmc">PMC3897394</ArticleId><ArticleId IdType="pubmed">24315484</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo YM, Li Z, Jiao Y, Gaborit N, Pani AK, Orrison BM, Bruneau BG, Giasson BI, Smeyne RJ, Gershon MD, Nussbaum RL. Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Hum. Mol. Genet. 2010;19:1633&#x2013;1650. doi: 10.1093/hmg/ddq038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq038</ArticleId><ArticleId IdType="pmc">PMC2850613</ArticleId><ArticleId IdType="pubmed">20106867</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith DR, Price JE, Burby PE, Blanco LP, Chamberlain J, Chapman MR. The production of curli amyloid fibers is deeply integrated into the biology of Escherichia coli. Biomolecules. 2017;7:75. doi: 10.3390/biom7040075.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom7040075</ArticleId><ArticleId IdType="pmc">PMC5745457</ArticleId><ArticleId IdType="pubmed">29088115</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>